Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo
- 12 April 2012
- journal article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 44 (7), 1139-1152
- https://doi.org/10.1016/j.biocel.2012.04.003
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81070823, 81170956)
This publication has 38 references indexed in Scilit:
- Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infectionJCI Insight, 2011
- IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: Differential involvement of NF-κB versus JNK/AP-1 pathwaysMolecular Immunology, 2011
- Bone resorption in syndromes of the Ras/MAPK pathwayClinical Genetics, 2010
- Anti-Inflammatory Effects of Licorice and Roasted Licorice Extracts on TPA-Induced Acute Inflammation and Collagen-Induced Arthritis in MiceJournal of Biomedicine and Biotechnology, 2010
- Epigallocatechin-3-gallate Inhibits Osteoclastogenesis by Down-Regulating c-Fos Expression and Suppressing the Nuclear Factor-κB SignalMolecular Pharmacology, 2009
- The Osteoclast: Friend or Foe?Annual Review Of Pathology-Mechanisms Of Disease, 2008
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathwayBiochemical and Biophysical Research Communications, 2006
- Functions of the MAPK family in vertebrate‐developmentFEBS Letters, 2006
- The evolving role of natural products in drug discoveryNature Reviews Drug Discovery, 2005